Canada to India: Syringe Import Trade Route
India has recorded 16 verified shipments of Syringe imported from Canada, representing a combined trade value of $2.9M USD. This corridor is served by 8 active Canada exporters, with an average shipment value of $179.8K USD. The leading Canada supplier is LABTICIAN OPHTHALMICS INC, which accounts for 90% of total import value with 1 shipments worth $2.6M USD. On the buying side, DELHI EYEZONE PRIVATE LIMITED is the largest Indian importer with $2.6M USD in purchases. The top 3 suppliers — LABTICIAN OPHTHALMICS INC, M/S TARO PHARMACEUTICALS INC, LABTICIAN OPHTHALMICS ,INC — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The Canada to India Syringe corridor is one of India's established pharmaceutical import routes from Canada, with 16 shipments documented worth a combined $2.9M USD. The route is dominated by LABTICIAN OPHTHALMICS INC, which alone accounts for roughly 90% of all import value, reflecting the consolidated nature of Canada's syringe export sector.
Across 8 active Canada suppliers, the average shipment value stands at $179.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with syringe's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 19.3%, placing it at rank #4 among India's top syringe import origins globally.
On the Indian buyer side, key Indian importers include DELHI EYEZONE PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, DELHI EYEZONE PRIVATE LIMITED and 4 others. DELHI EYEZONE PRIVATE LIMITED is the single largest Indian importer with 3 shipments valued at $2.6M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ1
- Primary modeSea freight
- Top port of entrySAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#4
- Annual growth+19.3%
- Demand growth+18.3%
- Regulatory ease83/100
Top 10 Syringe Exporters from Canada to India
Showing top 10 of 8 Canada suppliers exporting Syringe to India, ranked by total trade value (USD)
| Rank | Supplier (Canada Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LABTICIAN OPHTHALMICS INC Avg $2.6M per shipment | 1 | $2.6M | 89.7% |
| 2 | M/S TARO PHARMACEUTICALS INC Avg $36.8K per shipment | 5 | $183.9K | 6.4% |
| 3 | LABTICIAN OPHTHALMICS ,INC Avg $17.1K per shipment | 4 | $68.2K | 2.4% |
| 4 | LABTICIAN OPHTHALMICS ,INC Avg $10.0K per shipment | 2 | $20.1K | 0.7% |
| 5 | CELTIS HEALTHCARE LLC. Avg $13.3K per shipment | 1 | $13.3K | 0.5% |
| 6 | MS SEPTA PHARMACEUTICALS INV. Avg $6.0K per shipment | 1 | $6.0K | 0.2% |
| 7 | DELUX HEALTH GROUP INC. Avg $5.4K per shipment | 1 | $5.4K | 0.2% |
| 8 | BORA PHARMACEUTICAL SERVICES INC Avg $143 per shipment | 1 | $143 | 0.0% |
This table shows the top 10 of 8 Canada companies exporting syringe to India, ranked by total trade value. The listed exporters are: LABTICIAN OPHTHALMICS INC, M/S TARO PHARMACEUTICALS INC, LABTICIAN OPHTHALMICS ,INC , LABTICIAN OPHTHALMICS ,INC, CELTIS HEALTHCARE LLC., MS SEPTA PHARMACEUTICALS INV. , DELUX HEALTH GROUP INC., BORA PHARMACEUTICAL SERVICES INC . LABTICIAN OPHTHALMICS INC is the dominant supplier with 1 shipments worth $2.6M USD, giving it a 90% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Indian Syringe Importers from Canada
Showing top 10 of 7 known Indian buyers receiving Syringe shipments from Canada, ranked by import value
On the receiving end of this trade route, the leading Indian importers of Canada syringe include DELHI EYEZONE PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, DELHI EYEZONE PRIVATE LIMITED , INTAS PHARMACEUTICALS LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED , among 7 total buyers. The largest importer is DELHI EYEZONE PRIVATE LIMITED, accounting for $2.6M USD across 3 shipments — representing 90% of all syringe imports from Canada on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DELHI EYEZONE PRIVATE LIMITED | 3 | $2.6M | 90.4% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | 5 | $183.9K | 6.4% |
| 3 | DELHI EYEZONE PRIVATE LIMITED | 4 | $68.2K | 2.4% |
| 4 | INTAS PHARMACEUTICALS LIMITED | 1 | $13.3K | 0.5% |
| 5 | RELIANCE LIFE SCIENCES PRIVATE LIMITED | 1 | $6.0K | 0.2% |
| 6 | SWISS PARENTERALS LIMITED | 1 | $5.4K | 0.2% |
| 7 | SANDOZ PRIVATE LIMITED | 1 | $143 | 0.0% |
Top 10 Syringe Formulations Imported from Canada
Showing top 10 of 15 product formulations shipped on the Canada to India Syringe route, ranked by trade value
India imports a wide range of syringe formulations from Canada, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LS-1000 10ML SYRINGE SILICON OIL FOR RETINA SURGERY — accounts for $2.6M USD across 1 shipments. There are 15 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LS-1000 10ML SYRINGE SILICON OIL FOR RETINA SURGERY | 1 | $2.6M | 89.7% |
| 2 | LSO-LS-1000 10ML SYRINGE (SILICON OIL) (FOR RETINA SURGERY) | 2 | $45.2K | 1.6% |
| 3 | SOMATULINE AUGOGEL 120MG/SYRINGE,(1 PREFILLED SYRINGE/PACK)(LOT 008069)SOMATULINE AUGOGEL 120MG/SYRINGE,(1 PREFILLED SYRINGE/PACK) | 1 | $38.8K | 1.3% |
| 4 | SOMATULINE AUGOGEL 60MG/SYRINGE,(1 PREFILLED SYRINGE/PACK) (LOT 008490)SOMATULINE AUGOGEL 60MG/SYRINGE,(1 PREFILLED SYRINGE/PACK) ( | 1 | $38.7K | 1.3% |
| 5 | SOMATULINE AUGOGEL 90MG/SYRINGE,(1 PREFILLED SYRINGE/PACK) (LOT 009816)SOMATULINE AUGOGEL 90MG/SYRINGE,(1 PREFILLED SYRINGE/PACK) ( | 1 | $36.9K | 1.3% |
| 6 | SOMATULINE AUGOGEL 120MG/SYRINGE NON-BE SAMPLE (1 PREFILLEDSYRINGS/PACK)SOMATULINE AUGOGEL 120MG/SYRINGE NON-BE SAMPLE (1 PREFILLED | 1 | $34.7K | 1.2% |
| 7 | SOMATULINE AUGOGEL 120MG/SYRINGE NON-BE SAMPLE(1 PREFILLED SYRINGS/PACK)SOMATULINE AUGOGEL 120MG/SYRINGE NON-BE SAMPLE(1 PREFILLED S | 1 | $34.7K | 1.2% |
| 8 | LS-1000 10ML SYRINGE (SILICON OIL) (FOR RETINA SURGERY) | 1 | $17.5K | 0.6% |
| 9 | LSO-LS-1000 10ML SYRINGE (SILICON OIL) (FOR RETINA SURGERY) | 1 | $17.5K | 0.6% |
| 10 | MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP, 1 MLPREFILLED SYRINGE 150MG/ML-FOR TEST OR ANALYSIS PURPOSE ONLYMEDROXYPROGESTERONE ACETATE INJECTABLE S | 1 | $13.3K | 0.5% |
Showing top 10 of 15 Syringe formulations imported from Canada on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Indian Ports of Entry
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 6 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's syringe imports from Canada are driven primarily by a handful of large-scale Canada manufacturers. LABTICIAN OPHTHALMICS INC with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — Indian buyers benefit from Canada supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — LABTICIAN OPHTHALMICS INC, M/S TARO PHARMACEUTICALS INC, LABTICIAN OPHTHALMICS ,INC — together account for 98% of total trade value on this route. The average shipment value of $179.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as lso-ls-1000 10ml syringe (silicon oil) (for retina surgery) and somatuline augogel 120mg/syringe,(1 prefilled syringe/pack)(lot 008069)somatuline augogel 120mg/syringe,(1 prefilled syringe/pack), suggesting that Indian buyers tend to consolidate orders across related product lines from the same Canada supplier.
On the buying side, DELHI EYEZONE PRIVATE LIMITED is the largest importer with 3 shipments worth $2.6M USD — representing 90% of all syringe imports from Canada on this route. A total of 7 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.9M
- Avg. Shipment
- $179.8K
- Suppliers
- 8
- Buyers
- 7
- Transit (Sea)
- ~17 days
- Annual Growth
- +19.3%
Unlock the Full Canada to India Syringe Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16 shipments on this route.
Frequently Asked Questions — Canada to India Syringe Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Canada companies export Syringe to India?
The leading Canada exporters of Syringe to India are LABTICIAN OPHTHALMICS INC, M/S TARO PHARMACEUTICALS INC, LABTICIAN OPHTHALMICS ,INC . LABTICIAN OPHTHALMICS INC holds the largest market share at approximately 90% of total trade value on this route.
Q What is the total value of Syringe imports from Canada to India?
India imports Syringe from Canada worth approximately $2.9M USD across 16 recorded shipments. The average value per shipment is $179.8K USD.
Q Which Indian ports receive Syringe from Canada?
The most active Indian port of entry is SAHAR AIR CARGO ACC (INBOM4) with 6 shipments. Canada exporters primarily use sea freight for this route, with 79% of shipments going by sea and 26% by air.
Q How long does shipping take from Canada to India for Syringe?
The average transit time for Syringe shipments from Canada to India is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the Canada to India Syringe import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 19.3% with demand growth tracking at 18.3%. The route is ranked #4 among India's top Syringe import origins globally.
Q How many Canada suppliers are active on this Syringe import route?
There are currently 8 active Canada suppliers exporting Syringe to India. The market is moderately concentrated with LABTICIAN OPHTHALMICS INC accounting for 90% of total shipment value.
Q Who are the main Indian importers of Syringe from Canada?
The leading Indian importers of Syringe from Canada include DELHI EYEZONE PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, DELHI EYEZONE PRIVATE LIMITED , INTAS PHARMACEUTICALS LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED . DELHI EYEZONE PRIVATE LIMITED is the largest buyer with 3 shipments worth $2.6M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Canada export trade corridor identified from Indian Customs (DGFT) records for Syringe.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 7 importers in Canada matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists